Adult Left Ventricular Noncompaction Reappraisal of Current Diagnostic Imaging Modalities by Gati, Sabiha et al.
J A C C : C A R D I O V A S C U L A R I M A G I N G V O L . 7 , N O . 1 2 , 2 0 1 4
ª 2 0 1 4 B Y T H E AM E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 8 X / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j c m g . 2 0 1 4 . 0 9 . 0 0 5Adult Left Ventricular Noncompaction
Reappraisal of Current Diagnostic Imaging ModalitiesSabiha Gati, PHD, Ronak Rajani, MD, Gerald S. Carr-White, PHD, John B. Chambers, PHDABSTRACTFro
Kin
MaLeft ventricular noncompaction (LVNC) cardiomyopathy is morphologically characterized by prominent myocardial tra-
beculations and deep recesses. The precise stage of development and the natural history of the disorder are not fully
understood. Studies in heart failure patients demonstrate a high prevalence of myocardial trabeculations, raising the
potential diagnosis of LVNC. Given the high prevalence compared with other primary cardiomyopathies, it is unclear
whether the myocardial morphology is representative of LVNC or merely epiphenomena associated with increased cardiac
pre-load. Imaging modalities including echocardiography and cardiac magnetic resonance imaging facilitate identiﬁcation
and assessment for LVNC; however, current diagnostic criteria are based on small cohorts and are liable to result in an
overdiagnosis of LVNC. This review re-evaluates current diagnostic criteria and their potential impact on overdiagnosis of
LVNC in low-risk populations. (J Am Coll Cardiol Img 2014;7:1266–75) © 2014 by the American College of Cardiology
Foundation.L eft ventricular noncompaction (LVNC) cardio-myopathy is a new and as yet unclassiﬁed car-diomyopathy with an estimated prevalence of
0.014% to 0.17% (1,2). The disorder is morphologically
characterized by increased left ventricular (LV) trabe-
culation and intertrabecular recesses communicating
with the LV cavity. However, increased LV trabecula-
tion may be found in up to 30% of patients with LV
systolic dysfunction from any cause (3). It is therefore
unclear whether LVNC is more common than usually
supposed or whether increased trabeculation may be
an epiphenomenon of LV dilation. If so, then can it
also occur with physiological LV dilation associated
with increased cardiac pre-load? This review re-
evaluates current diagnostic criteria and their poten-
tial impact on overdiagnosis of LVNC in low-risk
populations.
CLASSIFICATION OF LVNC
Arbustini et al. (4). have recently proposed a novel
classiﬁcation system for cardiomyopathies termed
MOGE(S). The aim of this is primarily to provide a
pragmatic method of correlating the cause of dis-
ease with clinical phenotype by means of a single
notation. Using this system, cardiomyopathies may
be classiﬁed based on their morphofunctionalm the Department of Cardiology and Cardiac Imaging, Guy’s and St.
gdom. The authors have reported that they have no relationships releva
nuscript received August 24, 2014; revised manuscript received Septembcharacteristics (M), organ involvement (O), genetic or
familial inheritance pattern (G), etiology (E), and
functional status (S). Although it is appealing to
have a generic classiﬁcation that is applicable to all
cardiomyopathies, LVNC provides a number of spe-
ciﬁc challenges that potentially limits the use of
MOGE(S) for this condition. First, as well as exhibit-
ing considerable genetic and clinical heterogeneity,
LVNC may represent the morphological spectrum
of many phenotypically distinct cardiomyopathies
rather than a single, separate entity. The yield of
genetic testing in affected patients for LVNC is 40%
to 50%. LVNC has been linked to several mutations
in the sarcomeric, cytoskeletal, Z-line, and mito-
chondrial proteins; however, the ﬁnal common
pathway leading to the LVNC phenotype remains to
be elucidated (5,6). Secondly, there is considerable
heterogeneity in terms of functional capacity and
morphological change. Whereas some individuals
present with overt heart failure, fatal arrhythmias,
and thromboembolic events, others remain asymp-
tomatic (7). Finally, there remains a degree of
uncertainty as to the precise etiological factors
responsible for the development of LVNC. These
factors make a diagnosis of LVNC difﬁcult to estab-
lish and classiﬁcation with the MOGE(S) system
imperfect.Thomas’ NHS Foundation Trust, London, United
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FIGURE 1 Embryonic Development of LVNC
The myocardium starts off as a meshwork of ﬁbers that regress at weeks 5 to 8 to form
compacted outer and inner smooth muscle layers (A). In left ventricular noncompaction
(LVNC), there is retarded myocardial morphogenesis and persistence of the trabecular
meshwork (B).
AB BR E V I A T I O N S
AND ACRONYM S
CMR = cardiac magnetic
resonance imaging
CTA = computed tomographic
angiography
LV = left ventricular
LVNC = left ventricular
ompation
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1267PATHOGENESIS OF LVNC
There is controversy whether isolated LVNC is a
congenital abnormality as a result of the arrest of the
normal compaction process in utero or whether it is
acquired during life.
During the early embryological developmental
process, the myocardium is a loose meshwork of tra-
beculations and recesses that communicate with the
LV cavity (8). The myocardium becomes compacted
between the ﬁfth and eighth week, proceeding from
the basal segments to the apex and from epicardium
to endocardium (Figure 1). The congenital theory
proposes that the process of myocardial compaction
is disrupted through unknown mechanisms. The
severity of myocardial noncompaction is dependent
on the stage at which the arrest of the normal em-
bryonic myocardial maturation takes place.
The ability to acquire LVNC is supported by case
reports and studies demonstrating increased LV tra-
beculation developing on serial echocardiographic
assessment (9–11). Bleyl et al. (12) reported an absence
of LVNC features in 3 infants with fetal echocardiog-
raphy who were later diagnosed with LVNC. If LVNC
can be acquired, what are the triggers for this?
Microcirculatory dysfunction or a metabolic disorder
may cause myocardial ischemia or microinfarcts,
stimulating an increased trabecular response and
features consistent with LVNC (13). Autopsies have
identiﬁed subendocardial ﬁbrosis, suggesting that
myocarditis may be responsible in some cases.
Furthermore, it is also recognized that patients with
disease processes associated with chronically in-
creased LV pre-load and afterload, such as chronic
renal failure, heart valve disease (10), and sickle cell
disease (14), have a high prevalence of trabeculations
and may also fulﬁll criteria for LVNC. An increased
cardiac pre-load may be associated with an exagger-
ation in myocardial trabeculations as part of an
epiphenomenon rather than a primary cardiomyopa-
thy. In a recent study (15) of more than 1,000
asymptomatic athletes, 18% had increased LV trabe-
culation. However, 76 (8%) fulﬁlled echocardio-
graphic criteria for LVNC, of whom 10 (0.9%) had
T-wave inversion and reduced resting indices of sys-
tolic function that may be considered diagnostic of
LVNC. These ﬁndings may represent an incomplete
expression of the LVNC phenotype in predisposed
athletes unmasked through intensive exercise
(Figure 2) or an extreme form of cardiac adaptation to
exercise.
Gati et al. (16) studied pregnancy as a natural
model of increased pre-load. All 102 women had
completely normal echocardiograms at their bookingvisit, but 26 (25%) developed de novo trabe-
culations as pregnancy progressed. By a
mean 24 months after delivery, 19 (73%) had
complete resolution of trabeculations, and 6
had a marked reduction in the trabeculated
layer. One became pregnant again and was
excluded from follow-up. These data support
the theory that a cardiomyopathy is unlikely
even if there are criteria for LVNC when
symptoms of heart failure or a family history of
cardiomyopathy are absent.
It is likely that increased trabeculation is the ﬁnal
common pathway for interactions between a number
of genetic and acquired factors. For example, the
predisposition to increased LV trabeculation in
response to increased afterload may be genetically
determined. It has also been suggested that non-
compaction may compensate for abnormal myocar-
dial contractility from a genetic defect (6).
DIAGNOSIS OF LVNC
Two-dimensional echocardiography is the most
frequently used imaging modality, and 3 main sets of
criteria have been proposed to deﬁne LVNC (7). The
predominant feature common to all 3 is the presence
of a double-layered (compacted and noncompacted)
nonc
FIGURE 2 Potential Signiﬁcance of Increased LV Trabeculation in
Young Individuals Engaging in Intensive Physical Training
In the majority of athletes, increased LV trabeculation is likely to represent expressions
of physiological cardiac remodeling. However, a small minority may express a triad of
reduced LV systolic function, repolarization changes raising suspicion of left ventricular
noncompaction (LVNC). EF ¼ ejection fraction; LV ¼ left ventricle/ventricular; LVED ¼ left
ventricular end-diastolic diameter; LVH ¼ left ventricular hypertrophy. Adapted with
permission from Gati et al. (15).
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1268myocardial architecture. However, their individual
deﬁnitions for diagnosis of LVNC vary considerably,
making it difﬁcult to establish a ﬁrm diagnosis in
many clinical situations. Chin et al. (17) were the
ﬁrst to propose echocardiographic criteria based on 8
cases (mostly pediatric) validated by autopsy and a
control group of 8 normal subjects (Table 1). They
calculated the ratio of the distance from the epicar-
dial surface to the trough of the trabeculae (X) to the
distance from the epicardial surface to the peak of
the trabeculae (Y) measured at end-diastole (17). A
progressive decrease in the X/Y ratio was seen from
the base to apex in LVNC patients, but not in the 8
controls (17). Recent studies suggest that a ratio
of #0.5 based on measurements acquired in the
parasternal short-axis views are best for establishing
a diagnosis of LVNC (7). The criteria by Chin et al.
(17) do not specify a minimum number of trabecu-
lations required, the location of the noncompacted
segments, or the need to perfuse intertrabecular
recesses.
The Jenni et al. (18) criteria are the most
commonly used in clinical practice (Table 1): a
noncompaction-to-compaction ratio >2.0 at end-
systole on short-axis views; the absence of
other cardiac abnormalities; and color Dopplerdemonstrating perfusion of the intertrabecular re-
cesses. Jenni et al. (18) showed that noncompacted
segments were frequently in the mid-lateral and
inferior walls and apex. In their 34 individuals
with LVNC, the deﬁnition was validated in 7 patho-
anatomic specimens and against 9 patients with
hypertensive heart disease and 10 with dilated car-
diomyopathy. There was no comparison with normal
controls. Interestingly, the original work of Jenni
et al. described regional hypokinesia in the non-
compacted segments, and this was included in the
initial diagnostic criteria. However, on a subsequent
study (19) of 139 patients with cardiovascular disease,
regional hypokinesia showed low speciﬁcity and has
since been removed (7).
Stöllberger et al. (20) deﬁned LVNC as more than 3
individual trabeculations protruding from the LV wall
apical to the papillary muscle in 1 imaging plane
(Table 1). The Stöllberger et al. (20) deﬁnition was
based on a post-mortem analysis of 474 normal hearts
performed by Boyd et al. (21). The Stöllberger
et al. (20) criteria were further reﬁned to include a
2-layered myocardium with a ratio of noncompacted-
to-compacted myocardium >2.0 at end-diastole (22).
A fourth set of criteria (23) used a slightly different
methodology, measuring the LV trabeculations by
planimetry in 4-chamber views. Belanger et al. (23)
measured the LV trabeculations on echocardiography
by planimetry in 4-chamber views to diagnose LVNC.
They described the trabeculated areas of LVNC being
mild (<2.5 cm2), moderate (2.5 to 4.9 cm2), and severe
($5.0 cm2). Based on their assessment of 380 pa-
tients, 15.8% exhibited LVNC. However, their criteria
did not correlate with the modiﬁed Jenni et al.
(18) criteria and have not been validated.
LIMITATIONS OF ECHOCARDIOGRAPHIC ANALYSIS.
The current echocardiographic criteria for LVNC have
several limitations. The criteria were derived from a
small number of patients and have not been vali-
dated prospectively in larger cohorts of patients from
different ethnic origins. This was highlighted by
Kohli et al. (3), who showed that 24% of patients in
a general cardiology outpatient clinic with heart
failure fulﬁlled 1 or more criteria (Chin et al. [17],
Jenni et al. [18], and Stöllberger et al. [22]) for LVNC.
In addition, 8% of healthy black controls fulﬁlled
1 or more diagnostic criteria (3). This observation
raised the question whether the current echocar-
diographic criteria derived from Caucasian patients
are oversensitive in individuals of African/Afro-
Caribbean ethnicity. Uniformly accepted, anato-
mically controlled, echocardiographic diagnostic
criteria, possibly modiﬁed for ethnicities, are needed.
These criteria should be easily applicable and
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1269generally reproducible with low interobserver and
intraobserver variability.
The 2 most common pitfalls in establishing a
diagnosis of LVNC during echocardiographic assess-
ment are: 1) the identiﬁcation of abnormal trabecu-
lations; and 2) their accurate assessment. Abnormal
trabeculations can be mistaken for normal myocardial
trabeculations, false tendons, aberrant bands, cardiac
tumors, and LV apical thrombi (24). Incorrect inter-
pretation can be limited by recognizing relevant dis-
tinguishing features. Normal individuals usually
have <3 myocardial trabeculations that are located in
the LV apex (21). False tendons and aberrant bands
generally cross the LV cavity (25). LV apical thrombi
can be differentiated from LVNC by their different
echogenicity compared with the surrounding
myocardium (26). An awareness of LVNC and its
phenotypic presentations is likely to limit misdiag-
nosis. Should LVNC be suspected, it is important to
measure the trabeculations in the correct phase of the
cardiac cycle and the correct imaging plane, and also
to identify the compacted and noncompacted ratios
correctly in order that a correct ratio can be calculated
in accordance with the diagnostic criteria being used.
EMERGING ECHOCARDIOGRAPHIC TECHNIQUES
FOR LVNC. New echocardiographic techniques,
including tissue Doppler imaging, strain rate imaging,
and speckle tracking, are available to provide a more
objective and quantitative assessment of LVNC.
Myocardial strain values have been shown to be
abnormal in patients with LVNC even in the presence
of normal LV systolic/diastolic function. In a recent
study of 20 patients with LVNC and 20 age- and sex-
matched controls, Bellavia et al. (27) were able to
demonstrate a reduction in systolic strain, strain rate,
displacement, and rotation/torsion in patients with
LVNC that was independent of ejection fraction.
Additional studies have been both concordant (28,29)
and disconcordant (30) with these ﬁndings, thereby
casting doubt as to the discriminatory value of LV
twist and torsion mechanics in the setting of LVNC.
Additional morphological evaluation can be per-
formed with 3-dimensional echocardiographic anal-
ysis and contrast echocardiography (31,32). Both
techniques allow detailed, accurate assessment of the
number of trabeculations, compacted segments,
intertrabecular recesses, and trabecular volumes.
However, both techniques retain an element of user
dependency and experience to perform and interpret
the imaging ﬁndings.
CARDIAC MAGNETIC RESONANCE AND COMPUTED
TOMOGRAPHIC IMAGING. Cardiac magnetic reso-
nance imaging (CMR) is increasingly used to conﬁrm
the diagnosis of LVNC (Table 1). It is particularlyvaluable when echocardiographic image quality is
poor. Two sets of CMR criteria are in use, the ﬁrst
proposed by Petersen et al. (33) in 2005 and the other
by Jacquier et al. (34) in 2010. Petersen et al. (33)
tested the precision of CMR in the diagnosis of LVNC
in 177 individuals with and without cardiac disease.
Using cine CMR images, the authors were able to
identify a distinct 2-layered appearance of trabecu-
lated and compacted myocardium on the horizontal
and vertical long-axis and LV outﬂow tract views at
end-diastole in 7 patients with a clinical diagnosis of
LVNC. Interestingly, the authors also identiﬁed a
spectrum of noncompaction in patients with normal
or athletic hearts and in patients with known cardiac
disease (aortic stenosis, hypertension, hypertrophic
cardiomyopathy). The noncompaction was frequently
at the apex and lateral wall rather than the basal and
septal LV segments as seen in LVNC. On the basis of
these ﬁndings, Petersen et al. (33) proposed a non-
compaction/compaction ratio >2.3 in diastole as a cut
point for LVNC (Table 1). This gave a sensitivity of
86% and a speciﬁcity of 99% based on statistical
analysis of receiver-operating characteristics to
generate cutoff values to distinguish LVNC from all
other groups of subjects. However, the MESA (Multi-
Ethnic Study of Atherosclerosis) investigators found
that 43% of 329 patients with no cardiac disease or
hypertension achieved this cut point in 1 segment,
and 6% in at least 2 segments of the left ventricle
(35). This suggests that the Petersen criteria have low
speciﬁcity in patients at low risk of LVNC.
Jacquier et al. (34) calculated the LV trabecular
mass using steady-state free precession short-axis
views (Table 1). Based on the assessment of 16 pa-
tients (12 known and 4 suspected) with LVNC, and in
comparison with patients with dilated cardiomyopa-
thy, hypertrophic cardiomyopathy, and healthy con-
trols, a LV trabecular mass >20% of the total LV mass
was predictive of LVNC. The sensitivity and speci-
ﬁcity of the Jacquier criteria (34) was 93.7% based on
the Jenni et al. (18) criteria as the gold standard for
LVNC. Although the reproducibility of trabecular
mass percentage was not reported in this study,
subsequent evaluation of the Jacquier criteria in
other published literature has demonstrated a poor
interobserver variability (36).
A further question arises as to whether measure-
ments should be taken in end-diastole or end-
systole for the diagnosis of LVNC. Stacey et al. (37)
studied a retrospective cohort of 122 individuals
with reported trabeculations or LVNC on CMR. The
authors found that an end-systolic ratio >2 was a
strong predictor of existing heart failure (adjusted
odds ratio: 29.4; 95% conﬁdence interval: 6.6 to 125)
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1271but also combined clinical events (death, heart failure
readmission, embolic events, or ventricular arrhyth-
mias), (adjusted odds ratio: 8.6; 95% conﬁdence in-
terval: 2.5 to 33). However, this study was limited by
the retrospective analysis, small sample size, wide
conﬁdence intervals, and insufﬁcient information
on the natural history of patients with normal and
impaired systolic function. Therefore, it remains un-
clear whether end-systolic measurements are superior
to end-diastolic criteria for the diagnosis of LVNC
and associated clinical events.
Captur et al. (38) recently described a new CMR
technique, fractal analysis, which does not rely on the
conventional compacted-to-noncompacted ratio. It
summarizes global LV trabecular complexity as a
continuous variable termed fractal dimension (38).
Fractal analysis involves dividing 2-dimensional
space into a grid of boxes and counting the number
of boxes that contain part of the skeletonized data.
This is repeated for 4 different box sizes on the short-
axis cine stack (38). The exponent of the line-of-best
ﬁt across the points on the log-log plots of box count
represents the fractal dimension. Captur et al. (38)
validated their newmethodology using 3-dimensional
images of 24 embryonic murine hearts selected
between days 14.5 and 18.5 of cardiomorphogenesis
with high-resolution episcopic microscopy. As the
heart compacted, there was a fall in fractal dimension.
When this technique was applied to 135 human sub-
jects on CMR, 35 of whom had LVNC, a fractal
dimension $1.3 gave the optimal prediction for pa-
tients with LVNC with an area under the curve of 1.0.
This fractal approach was reproducible compared with
the techniques proposed by Petersen and Jacquier,
and more accurate in diagnosing LVNC based on
fractal dimension (intraclass correlation coefﬁcient
0.97 and 0.96 for intraobserver and interobserver
readings, respectively) (38). Although this technique
can be performed on any cardiac-enabled magnetic
resonance imaging scanner (1.5-T or 3.0-T), the sen-
sitivity of the methodology using different scanners,
different manufacturers, and varying scan parameters
has not been tested, and speciﬁc software is required.
The presence of contrast, noise artifact, and arrhyth-
mogenic load on fractal analysis also requires further
assessment. Further large-scale trials are indicated
in alternative patient populations.
CMR also offers direct characterization of myocar-
dial ﬁbrosis, which is an independent prognostic
marker in different types of cardiomyopathies (39–41).
Nucifora et al. (42) identiﬁed 42 patients with LVNC
using strict CMR criteria (2-layered myocardium with
excessive trabeculation and intertrabecular recesses,
and ratio of noncompacted-to-compacted layers
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1272>2.3). Late gadolinium enhancement, a surrogate of
myocardial ﬁbrosis, was observed in 23 (55%) patients.
Although, there was a strong association between the
presence and extent of delayed enhancement and
symptoms and LV ejection fraction, the prognostic
value of this technique has not been demonstrated
in LVNC patients with ventricular arrhythmias or
correlated to mortality. Late gadolinium enhance-
ment occurred in mid-myocardial segments or where
the right ventricle inserted into the left ventricle,
and was equally distributed in compacted and non-
compacted myocardium (42). Histological studies
show good agreement in LVNC between the pattern
of late gadolinium enhancement and scarring on
myocardial tissue obtained at the time of cardiac
transplantation or autopsy (43,44). In addition,
histological ﬁbrosis has also been identiﬁed in
noncompacted myocardium within the prominent
trabeculae (17,18) and within the thickened endocar-
dium (18). It is likely that increased wall stress, myo-
cyte necrosis, and progressive LV wall stress account
for the delayed enhancement seen within the mid-
myocardial segments, along with diminished coro-
nary ﬂow reserve within both the noncompacted and
compacted myocardium (45), as well as impaired
microvascular function.
Multidetector computed tomographic angiography
(CTA) may also be used to assess features of LVNC
(46). It provides excellent spatial and contrast reso-
lution for the evaluation of myocardial morphology
with the added advantage of providing information
relating to the coronary arteries and intrathoracic
vasculature. Although not usually recommended as
a ﬁrst-line investigation, it may be useful where
magnetic resonance imaging is contraindicated or
insufﬁcient image quality has been obtained echo-
cardiographically (47). It is important to note that
there are currently are no computed tomographic–
speciﬁc diagnostic criteria for LVNC. Because con-
ventional criteria recommend myocardial assessment
at end-systole or end diastole, a coronary CTA would
be required at 40% of the R-R interval for end-systole
and 0% or 90% of the R-R interval for end-diastole.
These phases may not be routinely available on a
low-dose, prospective, electrocardiographic-gated
coronary CTA. Furthermore, CTA is associated with
the disadvantage of radiation exposure, which may be
of particular relevance should serial studies be
required.
RIGHT VENTRICULAR NONCOMPACTION
Although there are no established diagnostic criteria
for noncompaction of the right ventricle, thisphenomenon has been reported in a number of cases.
Right ventricular noncompaction has been reported
in newborns with congenital heart defects and also in
adult patients presenting with neurological symp-
toms (48). Isolated right ventricular noncompaction
is an extremely rare occurrence in adults and usually
coexists with LVNC (49,50). The diagnosis has usually
been made using 3-dimensional echocardiography
from the presence of prominent right ventricular
trabeculations and a dilated hypokinetic right
ventricle (51). It is likely with the increasing avail-
ability of CMR that this condition will be better
identiﬁed and characterized in the future.
DIAGNOSTIC AND
CLINICAL EVALUATION OF LVNC
A multimodal diagnostic approach is the current
recommendation for the diagnosis of LVNC. Although
echocardiography may be limited by its dependence
on ultrasound windows and the skill of the operator,
it remains the front-line imaging modality of choice.
A thickened myocardium with a noncompacted-to-
compacted ratio >2 measured in a systolic short-axis
frame is the most commonly used diagnostic
threshold. Other echocardiographic functional pa-
rameters, including speckle tracking and strain, may
be helpful in borderline cases. Other ﬁndings sug-
gestive of cardiomyopathy are an E0 velocity <9 cm/s
and reduced LV contractile reserve on exercise (15). In
situations where image quality is poor on trans-
thoracic echocardiography, CMR may help suggest a
myopathic process by showing ﬁbrosis on late gado-
linium enhancement. However, current diagnostic
criteria are limited. The Petersen et al. (33) criteria
may result in overdiagnosis in low pre-test probabil-
ity populations, and the Jacquier et al. (34) criteria
have low reproducibility for trabecular mass per-
centage measurements (52). It is therefore generally
recommended that analysis by echocardiography and
CMR must be concordant to prevent overdiagnosis of
LVNC.
We propose an algorithm to guide the assessment
of individuals presenting with increased LV trabecu-
lations suggestive of LVNC, impaired resting LV
function, and abnormal electrocardiographic ﬁndings
(Figure 3). This algorithm was derived from our ob-
servations of both athletes with increased LV trabe-
culations and patients with LVNC (15). In the study by
Gati et al. (15) athletes were asymptomatic, whereas
75% of patients with LVNC had symptoms from LV
impairment. A minority of athletes with increased LV
trabeculation and reduced LV systolic function
(ejection fraction range of 45% to 50%) showed
FIGURE 3 Differentiating Physiological Increased LV Trabeculation From
Pathological LVNC
Clinical assessment and electrocardiographic and multi-imaging modalities are required for
cases in the grey zone of physiology and pathological noncompaction. AF ¼ atrial ﬁbril-
lation; CMR ¼ cardiac magnetic resonance imaging; LBBB ¼ left bundle branch block; VT ¼
ventricular tachycardia; other abbreviations as in Figure 2.
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1273normal indices of longitudinal LV function and dia-
stolic function. In comparison, patients with LVNC
often (66%) showed a LV diastolic diameter >64
mm, an ejection fraction <45%, suppressed longitu-
dinal LV function (systolic velocity <9 cm/s), and
impaired LV ﬁlling. On the 12-lead electrocardio-
gram, the pattern of T-wave inversion was different
between the 2 groups; the majority of athletes
showed T-wave inversion in V1 to V3, whereas pa-
tients with noncompaction show T-wave inversion
in the inferolateral leads. Following further com-
prehensive evaluation, a cardiopulmonary exercise
stress test followed by a peak exercise echo showed
that athletes had a high peak VO2 (>120% predicted
for age and size) and dynamic LV contraction,
whereas patients with LVNC had low peak VO2 and
persistently reduced LV function. The ﬁndings of
nonsustained ventricular tachycardia during exercise
in athletes with criteria for LVNC would suggest
pathology. The presence of late gadolinium en-
hancement on CMR would also suggest a car-
diomyopathic process. We recommend screening of
ﬁrst-degree relatives for features of LVNC; the
detection of another relative with a comparable
phenotype would support LVNC.
On the basis of the investigation proposed in the
algorithm, Gati et al. (15) did not feel there was suf-
ﬁcient evidence of a cardiomyopathy in the small
minority of athletes fulﬁlling criteria for LVNC with
repolarization changes and depressed basal systolic
function to warrant disqualiﬁcation from competitive
sport. During a subsequent follow-up period of over 4
years, none of these athletes experienced adverse
events. This algorithm was designed to aid the clini-
cian in a pragmatic approach to low-risk individuals
fulﬁlling criteria for LVNC.
CONCLUSIONS
The etiology and natural history and even the diag-
nosis of LVNC remain unclear and controversial. The
identiﬁcation of a high prevalence of LVNC in low-risk
populations such as athletes suggests that increased
LV trabeculation and recesses maybe epiphenomena
in response to a chronic increase in pre-load. Current
diagnostic criteria using echocardiography and CMR
are based on small cohorts and tend to overdiagnose
LVNC. In order to minimize this problem, we proposeguidance that integrates clinical, electrocardio-
graphic, and imaging characteristics.
FUTURE DIRECTIONS. There are still many unan-
swered questions in LVNC. Despite signiﬁcant
improvements in echocardiography and tissue har-
monics, there still remains a discrepancy and limita-
tions among the available published criteria for
diagnosis of LVNC. Future directions for accurate
diagnosis may incorporate a multimodality imaging
approach, possibly modiﬁed for ethnicities, with
particular focus on the functional diagnostic assess-
ment of LVNC. Multicenter collaboration is required to
build up a large international registry of patients with
LVNC for an improved understanding of this complex
cardiomyopathy to allow incorporation of genetics
and functional imaging to better deﬁne LVNC.
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